Patient organizations that serve people living with Atopic Eczema provide essential services, support, access to information, opportunities to link with other patients, and speak up for access to care and treatment. This is a disease where patient organizations are currently under-resourced and not well connected to each other, and as such, GlobalSkin began working with this broader community in 2018 to significantly and measurably improve linkages for patient organization leaders, capacity building and coordination of a synchronized strategic approach to improve access to care, critical information and treatment options for patients. In 2019, we will continue this important work.
Projects so far have included the launch of
GlobalSkin has created an online platform for the Atopic Eczema community (
Visit our global
World Atopic Eczema Day
What is it really like living with atopic eczema? On September 14, 2018, IADPO brought voice to patients and their caregivers by asking them that question in an online questionnaire on our new interactive online community
For a summary of Twitter discussions that took place that day,
Atopic Dermatitis (AD) Report
GlobalSkin co-sponsored an atopic dermatitis report with Pfizer which was published by The Economist Intelligence Unit on October 4, 2018.
The release of this publication was marked by a live webinar which featured a panel discussion that included our CEO Christine Janus. Read the news release and link to the report and watch the recorded webinar
GlobalSkin is grateful to its partners on this community building initiative: Sanofi Genzyme Regeneron, LEO Pharma and Pfizer.